{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T23:11:57Z","timestamp":1658531517788},"reference-count":38,"publisher":"Georg Thieme Verlag KG","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die medizinische Verwendung von Cannabis hat in den letzten Jahren in Europa und Nordamerika an Popularit\u00e4t gewonnen. Cannabinoide sind sowohl als Fertigarzneimittel als auch in Bl\u00fcten- und Extraktform verf\u00fcgbar. Der vorliegende Artikel legt den Fokus auf die supportive Therapie onkologischer Patienten. M\u00f6gliche Indikationen sind Schmerzen, Chemotherapie-bedingte \u00dcbelkeit und Erbrechen, Appetitlosigkeit und Geschmacksver\u00e4nderungen. Trotz des enormen Hypes um Cannabis als Medizin ist die Evidenz f\u00fcr dessen Anwendung bei onkologischen Patienten unzureichend. Palliativpatienten mit refrakt\u00e4ren Symptomen k\u00f6nnten jedoch geeignete Kandidaten f\u00fcr einen Therapieversuch darstellen. Der entscheidende Parameter f\u00fcr die Auswahl eines Cannabis-Arzneimittels ist die THC\/CBD-Ratio. Orale Einnahmeformen bieten sich gerade f\u00fcr Cannabis-naive und \u00e4ltere Patienten an. Psychische und kardiovaskul\u00e4re Nebenwirkungen sind nicht zu untersch\u00e4tzen.<\/jats:p>","DOI":"10.1055\/a-1872-2749","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T22:40:15Z","timestamp":1658529615000},"page":"916-922","source":"Crossref","is-referenced-by-count":0,"title":["Cannabis in der Onkologie \u2013 viel Rauch um nichts?"],"prefix":"10.1055","volume":"147","author":[{"given":"Anton","family":"Burkhard-Meier","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik III am Klinikum der LMU M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constanze","family":"R\u00e9mi","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Palliativmedizin am Klinikum der\u00a0LMU M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars H.","family":"Lindner","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik III am Klinikum der LMU M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"von Bergwelt-Baildon","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik III am Klinikum der LMU M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"ref2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1089\/pop.2018.0113","article-title":"Trends in Publications on Medical Cannabis from the Year 2000","volume":"22","author":"Y Treister-Goltzman","year":"2019","journal-title":"Popul Health Manag"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-021-03285-1","article-title":"3 Jahre Cannabis als Medizin \u2013 Zwischenergebnisse der Cannabisbegleiterhebung","author":"G Schmidt-Wolf","year":"2021","journal-title":"Bundesgesundheitsbl"},{"key":"ref4","first-page":"1","volume-title":"Cannabis, Cannabinoide und das Endocannabinoidsystem","author":"M Schneider","year":"2019"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrd.2018.115","article-title":"New approaches and challenges to targeting the endocannabinoid system","volume":"17","author":"V Di Marzo","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/dta.407","article-title":"Cannabis \u2013 from cultivar to chemovar","volume":"4","author":"A Hazekamp","year":"2012","journal-title":"Drug Test Anal"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/can.2016.0017","article-title":"Cannabis: From Cultivar to Chemovar II \u2013 A Metabolomics Approach to Cannabis Classification","volume":"1","author":"A Hazekamp","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/bph.2011.163.issue-7","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects LINKED ARTICLES","volume":"163","author":"E B Russo","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref13","first-page":"S12","article-title":"Unpicking the entourage effect","volume":"572","author":"T Worth","year":"2019","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/ejp.1297","article-title":"European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management","volume":"22","author":"W H\u00e4user","year":"2018","journal-title":"Eur J Pain"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/J.JPAINSYMMAN.2009.06.008","article-title":"Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of\u00a0the Efficacy, Safety, and Tolerability of\u00a0THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain","volume":"39","author":"J R Johnson","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines","volume":"29","author":"M Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009464.pub2","article-title":"Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy","volume":"2021","author":"L A Smith","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1365-2125.2010.03743.x","article-title":"Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting","volume":"70","author":"M Duran","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.annonc.2020.07.020","article-title":"Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial","volume":"31","author":"P Grimison","year":"2020","journal-title":"Ann Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/J.CTARC.2021.100336","article-title":"Appetite problem in cancer patients: Pathophysiology, diagnosis, and treatment","volume":"27","author":"T I Hariyanto","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1200\/JCO.2005.05.1847","article-title":"Comparison of orally administered cannabis extract and delta-9- tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannab","volume":"24","author":"F Strasser","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s00520-018-4154-9","article-title":"The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial","volume":"26","author":"J G Turcott","year":"2018","journal-title":"Support Care Cancer"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/annonc\/mdq727","article-title":"Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial","volume":"22","author":"T D Brisbois","year":"2011","journal-title":"Ann Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12273","article-title":"Systematic review and meta-analysis of cannabinoids in palliative medicine","author":"M M\u00fccke","year":"2018","journal-title":"R E V I E W"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.esmoop.2021.100092","article-title":"Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines","volume":"6","author":"J Arends","year":"2021","journal-title":"ESMO Open"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0035-1552741","article-title":"Klinische Ern\u00e4hrung in der Onkologie S3-Guideline of the German Society for Nutritional Medicine (DGEM) in Cooperation with the DGHO, the ASORS and the AKE Clinical Nutrition in Oncology","volume":"40","author":"A J Arends","year":"2015","journal-title":"Klin Ern\u00e4hrung \u2026 Aktuel Ernahrungsmed"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: A\u00a0systematic review and meta-analysis","volume":"313","author":"P F Whiting","year":"2015","journal-title":"JAMA \u2013 J Am Med Assoc"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3389\/fonc.2021.649555","article-title":"A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas","volume":"11","author":"J Schloss","year":"2021","journal-title":"Front Oncol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/sleep\/zsab234","article-title":"Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials","volume":"2021","author":"M Aminilari","year":"2021","journal-title":"SLEEPJ"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejim.2018.01.023","article-title":"Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer","volume":"49","author":"L Bar-Lev Schleider","year":"2018","journal-title":"Eur J Intern Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a Potenzial Treatment for Anxiety Disorders","volume":"12","author":"E M Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3389\/fpsyt.2021.729800","article-title":"Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial","volume":"12","author":"E L Martin","year":"2021","journal-title":"Front Psychiatry"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/s41386-020-0667-2","article-title":"Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials","volume":"45","author":"E Chesney","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and Pharmacodynamics of Cannabinoids","volume":"42","author":"F Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/J.MEHY.2005.08.026","article-title":"A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol","volume":"66","author":"E Russo","year":"2006","journal-title":"Med Hypotheses"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cpt.2071","article-title":"Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial","volume":"109","author":"P B Watkins","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"ref43","first-page":"1","article-title":"Medizinisches Cannabis \u2013 Die wichtigsten \u00c4nderungen","volume":"114","author":"K M\u00fcller-Vahl","year":"2017","journal-title":"Dtsch \u00c4rztebl"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"A L Geffrey","year":"2015","journal-title":"Epilepsia"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1634\/theoncologist.2018-0383","article-title":"Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies","volume":"24","author":"T Taha","year":"2019","journal-title":"Oncologist"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/bph.14426","article-title":"Anti-tumour actions of cannabinoids","volume":"176","author":"B Hinz","year":"2019","journal-title":"Br J Pharmacol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.22034\/APJCP.2017.18.1.3","article-title":"Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment","volume":"18","author":"F Hanif","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41416-021-01259-3","article-title":"A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma","volume":"124","author":"C Twelves","year":"2021","journal-title":"Br J Cancer"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.7326\/M21-4520","article-title":"Cannabis-Based Products for Chronic Pain. A Systematic Review","author":"M S Mc Donagh","year":"2022","journal-title":"Ann Intern med"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1872-2749.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T22:40:56Z","timestamp":1658529656000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1872-2749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":38,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2022,7,22]]},"published-print":{"date-parts":[[2022,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1872-2749","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}